Revenue Breakdown
Composition ()
No data
Revenue Streams
N2OFF Inc (NITO) generates its revenue primarily from Pathogen Prevention, which accounts for 100.0% of total sales, equivalent to $43.83K. Understanding this concentration is critical for investors evaluating how NITO navigates market cycles within the Agricultural Chemicals industry.
Profitability & Margins
Evaluating the bottom line, N2OFF Inc maintains a gross margin of 78.79%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -937.88%, while the net margin is -1904.55%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively NITO converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, NITO competes directly with industry leaders such as AXIL and GROV. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, NITO's gross margin of 78.79% stands against AXIL's 68.06% and GROV's 53.33%. Such benchmarking helps identify whether N2OFF Inc is trading at a premium or discount relative to its financial performance.
